About Nanovis
Nanovis is a company based in Columbia City (United States) founded in 2006. Nanovis has raised $26.86 million across 23 funding rounds from investors including 1st Source Bank, HHS and Global Health & Pharma. The company has 12 employees as of December 31, 2022. Nanovis offers products and services including Nanovis Spine, FortiCore, and Nano FortiFix Pedicle Screw. Nanovis operates in a competitive market with competitors including Spinal Simplicity, NanoHive, Moroxite F, Xenix Medical and FLUIDINOVA, among others.
- Headquarter Columbia City, United States
- Employees 12 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nanovis, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26.86 M (USD)
in 23 rounds
-
Latest Funding Round
$5.41 M (USD), Series A
Mar 25, 2020
-
Investors
1st Source Bank
& 6 more
-
Employee Count
12
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nanovis
Nanovis offers a comprehensive portfolio of products and services, including Nanovis Spine, FortiCore, and Nano FortiFix Pedicle Screw.
Technology for improving spinal implant integration and osseointegration.
Product enhancing fixation in orthopedic implants.
Screw technology for better implant stability and performance.
Funding Insights of Nanovis
Nanovis has successfully raised a total of $26.86M across 23 strategic funding rounds. The most recent funding activity was a Series A round of $5.41 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nanovis
Nanovis has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include 1st Source Bank, HHS and Global Health & Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Early-stage investments are made in diverse sectors by the firm.
|
Locked | Locked | Locked | |
|
Support for technology commercialization and startup development is provided.
|
Locked | Locked | Locked |
Investor details for Nanovis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nanovis
Investment portfolio details for Nanovis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nanovis
Detailed financials for Nanovis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanovis Comparisons
Peer comparison for Nanovis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nanovis
Nanovis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Spinal Simplicity, NanoHive, Moroxite F, Xenix Medical and FLUIDINOVA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Minimally invasive devices for spinal conditions are developed.
|
|
| Locked | Locked | Locked |
Developer of spinal interbody fusion implants
|
|
| Locked | Locked | Locked |
Regenerative medicine for fracture fixation in osteoporotic bone is developed.
|
|
| Locked | Locked | Locked |
Develops innovative medical devices for spinal fusion surgery procedures.
|
|
| Locked | Locked | Locked |
Synthetic nano-hydroxyapatite materials are manufactured and supplied.
|
Detailed competitors of Nanovis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanovis
Complete news archive for Nanovis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanovis
Nanovis was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Nanovis is headquartered in Columbia City, United States. It is registered at Columbia City, Oregon, United States.
Nanovis is a funded company, having raised a total of $26.86M across 23 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Nanovis is 12.
Nanovis was founded in 2006 and is based in Columbia City, United States, where operations focus on the medical device sector. Spinal implants incorporating nano-technology are produced, including deeply porous scaffolds, nano-patterned surfaces, and FortiCore interbody fusion devices. Developmental bactericidal technologies are also pursued, alongside titanium scaffolds for intervertebral spaces and inter-molded PEEK optima cores.
Nanovis's top competitors include Spinal Simplicity, NanoHive and Genesys Spine.
Nanovis offers Nanovis Spine, FortiCore, and Nano FortiFix Pedicle Screw.
Nanovis has 7 investors. Key investors include 1st Source Bank, HHS, Global Health & Pharma, Ellipsis Ventures, and Commenda Capital.